Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma

Liver Transplantation

Volumn 19, Issue 6, 2013, Pages 634-645

  Berry, Kristin ^a   Ioannou, George N ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLOOD CHEMISTRY; CANCER PATIENT; CHEMOEMBOLIZATION; CONTROLLED STUDY; CRYOTHERAPY; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGAN DONOR; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SERUM; SURGICAL MORTALITY; SURGICAL RISK; TUMOR VOLUME; UNITED STATES; BLOOD; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COHORT ANALYSIS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; UNITED STATES;

EID: 84878296941     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23652     Document Type: Article

References (17)

1. Bruix J, Sherman M,; for American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
2. Organ Procurement and Transplantation Network. Organ distribution: allocation of livers. http://optn.transplant.hrsa.gov/policiesAndBylaws/ policies.asp. Accessed March 2012.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
4. Bismuth H, Majno PE, Adam R,. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-322.
5. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
6. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
7. Ioannou GN, Perkins JD, Carithers RL Jr,. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008; 134: 1342-1351.
8. Berry K, Ioannou GN,. Are patients with Child's A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation? Am J Transplant 2012; 12: 706-717.
9. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM,. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009; 49: 832-838.
10. Mailey B, Artinyan A, Khalili J, Denitz J, Sanchez-Luege N, Sun CL, et al. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer. Arch Surg 2011; 146: 26-33.
11. United Network for Organ Sharing. http://www.unos.org. Accessed March 2012.
12. Ioannou GN,. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12: 1594-1606.
13. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
14. Cox DR,. Regression models and life-tables. J R Stat Soc Ser B 1972; 34: 187-220.
15. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP,. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007; 7: 2587-2596.
16. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al.; for Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
17. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16: 262-278.